SGYP

Synergy Pharmaceuticals, Inc. News Headlines

$3.05
*  
0.06
2.01%
Get SGYP Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading SGYP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SGYP Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Synergy Pharma Initiates First Phase 3 Clinical Trial Of Plecanatide For IBS-C
12/18/2014 6:33:00 AM - RTT News


Synergy Pharmaceuticals Drug Fares Well in Phase II Study - Analyst Blog
11/20/2014 4:34:00 PM - Zacks.com


CBMG To Keep On Your Radar, CEMP Gets Funding, MACK On Fast Track
11/20/2014 3:17:00 AM - RTT News


Synergy's SP-333 Phase 2 Trial Shows Positive Results
11/19/2014 8:43:00 AM - RTT News


Synergy Pharma To Present At Credit Suisse Conference; Webcast At 4:30 PM ET
11/12/2014 3:00:00 PM - RTT News


Synergy Pharmaceuticals, Inc. (SGYP) Surges: Stock Rises 10% - Tale of the Tape
10/30/2014 8:11:00 AM - Zacks.com


Warning -- The Recent Sell-Off Could Be Just the Beginning
10/28/2014 5:30:00 AM - Investopedia


These 3 Stocks May Now Have 100% Upside Potential
10/27/2014 7:00:00 AM - Investopedia


3 Under-The-Radar Stocks With 100% Upside
10/27/2014 7:00:00 AM - Investopedia


Synergy Pharma presents plecanatide IBS-C clinical trial results
10/21/2014 10:11:00 AM - Seeking Alpha


Synergy Reports Results From Phase 2b Plecanatide Study - Quick Facts
10/21/2014 6:15:00 AM - RTT News


Synergy Pharmaceuticals Could Be A Diamond In The Rough
9/8/2014 12:30:00 PM - Seeking Alpha


Trouble For Synergy Pharmaceuticals Shorts With Pending SP-333 Trial Results
8/15/2014 7:24:00 PM - Seeking Alpha


Synergy Pharma (SGYP) Posts Wider-than-Expected Loss in Q2 - Analyst Blog
8/13/2014 2:03:00 PM - Zacks.com


Update: Synergy Pharmaceuticals Patient Enrollment
7/28/2014 7:01:00 AM - Seeking Alpha


Jazz Pharmaceuticals/Concert Pharmaceuticals Start Study - Analyst Blog
7/22/2014 4:25:00 PM - Zacks.com


Anacor's Kerydin to Be Commercialized by Sandoz in the U.S. - Analyst Blog
7/22/2014 4:05:00 PM - Zacks.com


Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% - Tale of the Tape
7/22/2014 7:44:00 AM - Zacks.com


Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog
7/21/2014 3:07:46 PM - Zacks.com


Synergy Pharmaceuticals Progresses with Mid-Stage Candidate - Analyst Blog
7/18/2014 5:15:00 PM - Zacks.com


Salix-Pharming's Ruconest Gets FDA Nod for HAE - Analyst Blog
7/18/2014 5:00:00 PM - Zacks.com


Astellas' Isavuconazole Gets QIDP for Invasive Candidiasis - Analyst Blog
7/17/2014 4:50:00 PM - Zacks.com


Genocea Biosciences, Inc. (GNCA) in Focus: Stock Rises 7.52% - Tale of the Tape
7/17/2014 7:44:00 AM - Zacks.com


Weakness Seen in Lannett Company (LCI): Stock Tumbles 17.1% - Tale of the Tape
7/17/2014 7:36:00 AM - Zacks.com


Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog
7/16/2014 2:03:00 PM - Zacks.com